chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.79
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/20/03 concerning an unspecified number of vaccinees under the age of 4 years who inadvertently received Fluvirin on unspecified dates. On unspecified dates the vaccinees inadvertently received Fluvirin IM. At the time of reporting the reporter had not been informed of any subsequent adverse events. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information was received from a health care professional indicating that the vaccinee was a 21 month old male who inadvertently received Fluvirin on 11/19/03. No adverse events were reported at the time of the report. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/20/03 concerning an elderly female vaccinee who received Fluvirin on 11/10/03 and inadvertently received a further dose of Fluvirin on 11/20/03. On 11/10/03 the vaccinee received 0.5ml Fluvirin IM. On 11/20/03 the vaccinee received another dose of 0.5ml Fluvirin IM. At the time of reporting the reporter was not aware of any subsequent adverse events. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/20/03 concerning a male vaccinee of unspecified age who inadvertently received ID Fluvirin on an unspecified date. On an unspecified date the vaccinee inadvertently received ID Fluvirin instead of tuberculin purified protein derivative. At the time of reporting the vaccinee did not exhibit any adverse events. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Loss of consciousness
Clinical narrative: A report was received from a consumer through their insurance company on 11/20/03 who is a female vaccinee of unspecified age who blacked out while driving her automobile, seven minutes after receiving Fluvirin on 10/20/03. On 10/20/03 the vaccinee blacked out while driving her automobile as a result of the vaccinee hit a fire hydrant. At the time of the report the outcome was not reported. Update 2/9/04: A follow up report was received from a health care professional indicating that the vaccinee was treated and released by an emergency department. The reporter did not see the vaccinee before, during or immediately after the incident. Follow up pending.
Age: 10.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: A report was received from a consumer on 11/21/03 concerning a 9 year old female vaccinee who experienced hives the night after receiving Fluvirin on 11/20/03. On 11/20/03 the vaccinee received Fluvirin and that night developed red bumps or hives that resembled bug bites. Hydrocortisone was applied to the affected area. On 11/21/03 the vaccinee developed more hives which were larger in size. The hives were treated with diphenhydramine hydrochloride. The vaccinee previously received a dose of the influenza vaccine for the past two years without any problems and has no history of hypersensitivity. The reporter did not know the outcome of the hives at the time of the report. Update 2/16/04: Follow up information received from a health care professional indicated that the vaccinee developed abdominal hives on 11/21/03 following administration of Fluvirin. The event resolved on an unspecified date. Follow up pending.
Age: 1.34
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 16 month old vaccinee (gender unspecified) who inadvertently received Fluvirin on 11/24/03. On 11/24/03, the vaccinee inadvertently received 0.25ml Fluvirin. The dose was to be a booster dose to the initial dose that was previously administered. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1/9/04: A follow up report was received from a health care professional indicating that a 16 month old male vaccinee inadvertently received Fluvirin on 11/24/03. No adverse symptoms were reported at the time of reporting. No follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a female vaccinee of unknown age who was inadvertently administered frozen Fluvirin vaccine on 11/24/03. On 11/24/03, the vaccinee inadvertently received Fluvirin, which had been left adjacent to a freezer compartment and was subsequently frozen. The vaccinee will be advised to receive Fluvirin again in 3 weeks time. It was not reported if the vaccinee had experienced any adverse reaction. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.85
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 22 month old male vaccinee who inadvertently received Fluvirin on 11/24/03. On 11/24/03, the vaccinee inadvertently received 0.25ml Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 4/26/04: Further information was received from a health care professional indicating that the vaccinee experienced no obvious adverse events at the time of injection. The vaccinees mother was immediately notified and asked to call if the vaccinee developed any adverse events. The vaccinees mother has not called back to date. No follow up pending, all information received.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a consumer on 11/24/03 concerning a vaccinee (gender unspecified) under 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date the vaccinee inadvertently received Fluvirin. No adverse symptoms were reported at the time of reporting. Follow up pending.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 60 year old female vaccinee who inadvertently received expired Fluvirin on 11/10/03. On 11/10/03, the vaccinee inadvertently received expired Fluvirin. The vaccinee had not experienced any adverse effects as a result at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 3/8/04: Follow up information received from a health care professional indicated that the vaccinee did not experience any adverse reactions following vaccination with expired Fluvirin. No follow up pending, all information received.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a consumer on 11/22/03 concerning a 2 year old male vaccinee who inadvertently received Fluvirin on 11/22/03. On 11/22/03 the vaccinee inadvertently received Fluvirin. No adverse symptoms were exhibited at the time of reporting. Follow up pending.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 52 year old female vaccinee who inadvertently received expired Fluvirin vaccine on 11/10/03 approximately. On 11/10/03 approximately, the vaccinee inadvertently received expired Fluvirin. It was not reported if the vaccinee had experienced any adverse reaction. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 54 year old female vaccinee who inadvertently received expired Fluvirin vaccine on 11/10/03 approximately. On 11/10/03 approximately, the vaccinee inadvertently received expired Fluvirin. It was not reported if the vaccinee had experienced any adverse reaction. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 1 year old male vaccinee who inadvertently received Fluvirin on 10/20/03. On 10/20/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 2 year old female vaccinee who inadvertently received Fluvirin on 10/20/03. On 10/20/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting, the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 2 year old male vaccinee who inadvertently received Fluvirin on 10/27/03. On 10/27/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 0.6
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 7 month old female vaccinee who inadvertently received Fluvirin on 10/27/03. On 10/27/03, the vaccinee received a single dose of Fluvirin 0.25ml. At the time of reporting the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 3 year old male vaccinee who inadvertently received Fluvirin on 10/27/03. On 10/27/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting, the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/25/03 concerning a 60 year old female vaccinee who received one dose of influenza vaccine (brand unspecified) on an unspecified date in October 2003 and then inadvertently received Fluvirin on 11/25/03. In October 2003, the vaccinee received a dose of influenza vaccine (brand unspecified) and on 11/25/03 the vaccinee received a dose of Fluvirin. At the time of the report, no adverse events have been reported. There was insufficient information to determine the reporter's causality assessment. No follow up pending.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 2 year old female vaccinee who inadvertently received Fluvirin on 10/27/03. On 10/27/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting, the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 10/27/03. On 10/27/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting, the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/28/03 concerning approximately 40 vaccinees between the ages of 4-9 years and of unknown gender, who inadvertently received 0.24ml of Fluvirin between 10/6/03 and 11/21/03. Between 10/6/03 and 11/21/03, the vaccinees inadvertently received 0.25ml of Fluvirin. It was reported that no adverse events had occurred as a result, at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 2 year old female vaccinee who inadvertently received Fluvirin on 10/29/03. On 10/29/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 0.53
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/25/03 concerning a 6 month old female vaccinee who inadvertently received Fluvirin on 11/04/03. On 11/4/03 the vaccinee inadvertently received 0.25ml of Fluvirin. At the time of the report, no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 3/11/04: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received.
Age: 1.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 11/10/03 concerning a 1 year old male vaccinee who inadvertently received Fluvirin on 11/4/03. On 11/4/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting, the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 3 year old male vaccinee who inadvertently received Fluvirin on 11/4/03. On 11/4/03, the vaccinee received a single dose of Fluvirin 0.5ml. At the time of reporting, the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.57
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/25/03 concerning a 20 month old male vaccinee who was inadvertently administered Fluvirin on 11/25/03. On 11/25/03, the vaccinee was inadvertently administered Fluvirin. The vaccinee had not experienced any adverse effects as a result at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 3/11/04: A follow up report was received from a health care professional who indicated that the vaccinee did not experience any adverse symptoms. The vaccinee had received his first shot of Fluzone on 10/21/03. No follow up pending, all information received.
Age: 1.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning a 1 year old female vaccinee who inadvertently received Fluvirin on 11/4/03. On 11/4/03, the vaccinee received a single dose of Fluvirin 0.25ml. At the time of reporting the vaccinee did not exhibit any adverse effects. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/25/03 concerning a 1 year old male vaccinee who was inadvertently administered 0.5ml Fluvirin vaccine on 11/24/03. On 11/24/03 the vaccinee inadvertently received 0.5ml Fluvirin. At the time of the report the outcome was not reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Follow up letter returned unopened on 8/3/04. No new information provided.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/25/03 concerning a 2 year old male vaccinee who was inadvertently administered 0.5ml Fluvirin vaccine on 11/24/03. On 11/24/03 the vaccinee inadvertently received 0.5ml Fluvirin. At the time of the report the outcome was not reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Follow up letter returned unopened on 8/3/04. No new information provided.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 63 year old female vaccinee who was inadvertently administered frozen Fluvirin vaccine on an unreported date. On unknown date, the vaccinee inadvertently received Fluvirin, which had been left adjacent to a freezer compartment and was subsequently frozen. The vaccinee will be advised to receive Fluvirin again in 3 weeks time. It was not reported if the vaccinee had experienced any adverse reaction. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 37 year old female vaccinee who was inadvertently administered frozen Fluvirin vaccine on an unspecified date. On an unknown date, the vaccinee inadvertently received Fluvirin, which had been left adjacent to a freezer compartment and was subsequently frozen. The vaccinee will be advised to receive Fluvirin again in 3 weeks time. It was not reported if the vaccinee had experienced any adverse reaction. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 64 year old male vaccinee who was inadvertently administered frozen Fluvirin vaccine on an unreported date. On an unknown date, the vaccinee inadvertently received Fluvirin, which had been left adjacent to a freezer compartment and was subsequently frozen. The vaccinee will be advised to receive Fluvirin again in 3 weeks time. It was not reported if the vaccinee had experienced any adverse reaction. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 60 year old female vaccinee who was inadvertently administered frozen Fluvirin on an unreported date. On an unknown date, the vaccinee inadvertently received Fluvirin, which had been left adjacent to a freezer compartment and was subsequently frozen. The vaccinee will be advised to receive Fluvirin again in 3 weeks time. It was not reported if the vaccinee had experienced any adverse reaction. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/24/03 concerning a 69 year old female vaccinee who was inadvertently administered frozen Fluvirin vaccine on an unreported date. On an known date, the vaccinee inadvertently received Fluvirin, which had been left adjacent to a freezer compartment and was subsequently frozen. The vaccinee will be advised to receive Fluvirin again in 3 weeks time. It was not reported if the vaccinee had experienced any adverse reaction. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/26/03 concerning a 44 year old female vaccinee who was administered Fluvirin vaccine in the buttocks on 11/5/03. On 11/5/03, the vaccinee requested Fluvirin be administered in the buttocks instead of the deltoid. The vaccinee had not exhibited any signs or symptoms of an adverse event at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/26/03 concerning a 45 year old female vaccinee who was administered Fluvirin vaccine in the buttocks on 10/30/03. On 10/30/03, the vaccinee requested Fluvirin be administered in the buttocks instead of the deltoid. The vaccine had not exhibited any signs or symptoms of an adverse event at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.2
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/26/03 concerning a 14 month old female vaccinee who was inadvertently administered Fluvirin vaccine 11/26/03. On 11/26/03, the vaccinee was administered 0.25ml Fluvirin. No adverse effects were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional concerning a 66 year old female vaccinee who inadvertently received expired Fluvirin SC on 11/10/03. On 11/10/03, the vaccinee inadvertently received expired Fluvirin SC. The vaccinee had not experienced any adverse event at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/14/03 concerning a 75 year old female vaccinee who inadvertently received expired Fluvirin SC on 11/10/03. On 11/10/03, the vaccinee inadvertently received expired Fluvirin SC. The vaccinee did not experience any adverse events at the time of this report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/14/03 concerning a 73 year old male vaccinee who inadvertently received expired Fluvirin SC on 11/10/03. On 11/10/03, the vaccinee inadvertently received expired Fluvirin SC. The vaccinee did not experience any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/14/03, concerning a 51 year old male vaccinee who inadvertently received expired Fluvirin SC on 11/11/03. On 11/11/03, the vaccinee inadvertently received expired Fluvirin SC. The vaccinee did not experience any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 49.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/14/03 concerning a 49 year old male vaccinee who inadvertently received expired Fluvirin SC on 11/11/03. On 11/11/03, the vaccinee inadvertently received expired Fluvirin SC. The vaccinee did not experience any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 82.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/14/03 concerning an 82 year old male vaccinee who inadvertently received expired Fluvirin SC on 11/11/03. On 11/11/03, the vaccinee inadvertently received expired Fluvirin SC. The vaccinee did not experience any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 74.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/14/03 concerning a 74 year old male vaccinee who received expired Fluvirin SC on 11/11/03. On 11/11/03, the vaccine received expired Fluvirin SC. The vaccinee had not experienced any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/26/03 concerning a 3 year old female vaccinee who was inadvertently administered Fluvirin vaccine 11/26/03. On 11/26/03, the vaccinee was administered 0.25ml Fluvirin. No adverse effects were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.98
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/24/03 concerning 3 vaccinees of unknown gender less than 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date, 3 vaccinees less than 4 years of age inadvertently received Fluvirin. It was unknown at the time of the report whether or not the vaccinees had exhibited any signs or symptoms of an adverse reaction. There was insufficient information to determine the reporter's causality assessment. Update 11/24/03: Further information was received from a health care professional on 11/24/03 indicating the vaccinee was a 2 year old female who inadvertently received 0.25ml Fluvirin vaccine on 10/21/03. On 10/21/03 the vaccinee inadvertently received Fluvirin. No adverse events were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 0.77
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/24/03 concerning 3 vaccinees of unknown gender less than 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date 3 vaccinees less than 4 years of age inadvertently received Fluvirin. It was unknown at the time of the report whether or not the vaccinees had exhibited any signs or symptoms of an adverse reaction. There was insufficient information to determine the reporter's causality assessment. Update 11/24/03: Further information was received from a health care professional on 11/24/03 indicating that the vaccinee was a 10 month old male who inadvertently received 0.25ml Fluvirin vaccine on 10/13/03. On 10/13/03, the vaccinee inadvertently received Fluvirin. No adverse events were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/24/03 concerning 3 vaccinees of unknown gender less than 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date 3 vaccinees less than 4 years of age inadvertently received Fluvirin. It was unknown at the time of the report whether or not the vaccinees had exhibited any signs or symptoms of an adverse reaction. There was insufficient information to determine the reporter's causality assessment. Update 11/24/03: Further information was received from a health care professional on 11/24/03 indicating that the vaccinee was a 27 month old male who inadvertently received 0.25ml Fluvirin vaccine on 11/3/03. On 11/3/03, the vaccinee inadvertently received Fluvirin. No adverse events were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/24/03 concerning 3 vaccinees of unknown gender less than 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date 3 vaccinees less than 4 years of age inadvertently received Fluvirin. It was unknown at the time of the report whether or not the vaccinees had exhibited any signs or symptoms of an adverse reaction. There was insufficient information to determine the reporter's causality assessment. Update 11/24/03: Further information was received from a health care professional on 11/24/03 indicating that the vaccinee was a 3 year old male who inadvertently received 0.25ml Fluvirin vaccine on 11/3/03. On 11/3/03 the vaccinee inadvertently received Fluvirin. No adverse events were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/1/03 concerning an unspecified number of vaccinees less than 4 years of age and of unknown sex who inadvertently received Fluvirin on approximately 11/17/03. On approximately 11/17/03 multiple vaccinees less than 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Arthritis, Bursitis, Pain
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning a female vaccine (age unspecified) who experienced local pain and later developed right shoulder arthritis/bursitis after she received Fluvirin on 10/28/03. On 10/28/03, the vaccinee received Fluvirin into the right arm 1cm below the right shoulder joint. The vaccinee experienced local pain at the time of the vaccination. The vaccinee later developed right shoulder arthritis/bursitis that had not resolved at the time of reporting. The vaccinee was referred to an orthopedic surgeon for follow up. The reporter stated that the Fluvirin injection might possibly have been administered into the shoulder joint. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Accidental overdose, Medication error
Clinical narrative: A report was received from a health care professional on 12/02/03 concerning a 65 year old male vaccinee who inadvertently received two doses of Fluvirin on unspecified dates, two weeks apart. On unspecified dates a 65 year old male vaccinee inadvertently received two doses of Fluvirin, two weeks apart. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning a vaccine, demography unknown who inadvertently received Fluvirin via the SC route on 12/2/03. On 12/2/03, the vaccinee inadvertently received Fluvirin via the SC route. No adverse symptoms were reported at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on unspecified dates. On unspecified dates until 12/1/03 vaccinees inadvertently received Fluvirin. The vaccinees did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning 7 vaccinees under 4 years of age who inadvertently received Fluvirin on unspecified dates. On unspecified dates, the vaccinees inadvertently received Fluvirin. The vaccinees did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 7.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning a 7 year old female vaccinee who inadvertently received 0.25ml Fluvirin on 12/1/03. On 12/1/03, the vaccinee inadvertently received 0.25ml instead of 0.5ml of Fluvirin. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 3/22/04: Further information was received from a health care professional indicating that the vaccinee was vaccinated again with the correct dose of Fluvirin on 12/11/03. The vaccinee did not experience any adverse reaction at the time of the report. Follow up received 6/30/04 reporting no adverse events after the vaccinee was revaccinated on 12/11/04.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning a 47 year old female vaccinee who inadvertently received Fluvirin via the IM route in the buttocks on 11/21/03. On 11/21/03, the vaccinee received Fluvirin IM in the buttocks. The vaccinee had surgery on one arm and she was having a problem with her other arm, and therefore requested and received Fluvirin in her buttocks. No adverse symptoms were reported at the time reporting. There was insufficient information to determine the reporter's causality assessment. Update 4/13/04: Follow up information from a health care professional indicated that the vaccinee did not experience any adverse events and did not require repeat vaccination with Fluvirin. No follow up pending, all information received.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning an unspecified number (approximately 5 to 6) vaccinees under 4 years of age who inadvertently received Fluvirin on unspecified dates. On unspecified dates, the vaccinees inadvertently received Fluvirin 0.5ml IM. The vaccine did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1/20/04: A follow up report was received from a health care professional concerning a 2 year old female vaccinee who inadvertently received Fluvirin on 11/25/03. On 11/25/03 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. No follow up pending, all information received.
Age: 1.61
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning a 19 month male vaccinee who inadvertently received Fluvirin on 11/30/03. On 11/30/03, a vaccinee under 4 years of age inadvertently received Fluvirin. At the time of the report no adverse had been reported. There was insufficient information to determine the reporter's causality assessment. Update 4/13/04: Follow up information received from a health care professional indicated that the vaccinee received a second dose of Fluvirin on an unspecified date. The vaccinees' parents were contacted in January 2004 and stated that the vaccinee did not experience any adverse events. No follow up pending, all information received.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning a 3 year old female vaccinee who received a dose of Fluzone on 10/29/03 and the inadvertently received a dose of Fluvirin instead of a second dose of Fluzone on 11/28/03. On 10/29/03 a female vaccinee received a dose of Fluzone and on 11/28/03 the vaccinee inadvertently received a dose of Fluvirin instead of a second dose of Fluzone. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 3/10/04: Follow up information received from a health care professional indicated that the vaccinee also received an accidental overdose of 0.5ml of Fluvirin. No adverse events have been reported to date. No follow up pending, all information received.
Age: 1.97
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning eight vaccinees of unspecified sex and under 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date, eight vaccinees under 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality. Update 1/20/04: Follow up information received from a health care professional indicated that a 2 year old male vaccinee inadvertently received Fluvirin on 11/24/03. No follow up pending.
Age: 0.58
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 12/3/03 concerning a 6 month old male vaccinee who was inadvertently administered Fluvirin on 12/2/03. On 12/3/03, the vaccinee inadvertently received 0.25ml of Fluvirin. No adverse effects were reported at time of report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Discomfort, Myalgia, Pain, Sleep disorder
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning a 53 year old female vaccinee who experienced muscle aches, pain, a dull, achy pain in her left arm and a twinge of pain in her left arm and is unable to sleep on her left side on 11/7/03 after receiving 0.5ml Fluvirin vaccine on the same day. On 11/7/03, the vaccinee experienced muscle aches and pain following administration of Fluvirin. Soon after administration the vaccinee experienced a dull, achy pain in her left arm. The vaccinee took 3 Advil and the pain and achiness subsided. The vaccinee continues to experience discomfort in the left deltoid muscle. However, she has not experienced fever and the injection has not become red or swollen. When the vaccinee is not moving, she experiences a dull ache in her left arm and when she moves she feels a twinge of pain in her arm. The vaccinee cannot sleep on her left side due to the pain in her left arm. The vaccinee is not taking any other medications and has received the flu vaccine in the past without any complications following vaccination. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning a 50 year old female vaccinee who inadvertently received Fluvirin SC on 10/23/03. On 10/23/03, a female vaccinee inadvertently received Fluvirin SC. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning a 2 year old male vaccinee who inadvertently received Fluvirin on the same day. On 12/3/03 a 2 year old male vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning approximately 2-3 children of unknown sex and between the ages of 2 to 3 years who inadvertently received Fluvirin on an unspecified date. On an unspecified date approximately 2-3 children between the ages of 2 to 3 years inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality. Follow up pending.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Cystitis interstitial, Dysuria, Micturition urgency, Vaginal ulceration
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning a female vaccinee in her 40's who developed a vaginal ulcer with symptoms to burning on urination and urgency on 11/13/03 after receiving Fluvirin vaccine on 11/12/03. Within 24 hours of receiving Fluvirin on 11/12/03 the vaccinee developed a vaginal ulcer with symptoms of burning on urination and urgency. The vaccinee was seen by the OB/GYN and was prescribed a vaginal anti-fungal cream for 4 days. The vaccinees vaginal ulcer resolved following completion of the anti-fungal therapy, however, she still complains of burning on urination and a feeling of urgency. The vaccinee was restarted on the vaginal anti-fungal cream and continues this therapy. The vaccinee had a test for yeast yielding negative results. Update 1/24/04: A follow up report was received from a health care professional indicating that a urologist treated the vaccine. She was given multiple medications including anti-inflammatories and antibiotics. The urologist felt that the vaccinee had interstitial cystitis which had no relationship to the flu vaccine. At the time of the follow up report the ulcer had disappeared but the urinary symptoms were unresolved. Update 2/23/04: A follow up report was received from a health care professional indicating that the vaccinee has been diagnosed with interstitial cystitis and continues to have symptoms. No follow up pending, all information received.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning a female vaccinee of unspecified age who inadvertently received Fluvirin SC on 12/2/03. On 12/2/03 the vaccinee inadvertently received Fluvirin SC with a 27G needle instead of IM. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 4/16/04: Follow up information received from an unidentified source indicated that the adult vaccinee did not experience any adverse events. No follow up pending, all information received.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning a 30 year old female vaccinee who inadvertently received expired Fluvirin vaccine on 12/3/03. On 12/3/03 the vaccinee was administered 2002-2003 Fluvirin. No adverse events were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 31.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning a 31 ear old male vaccinee who inadvertently received expired Fluvirin vaccine on 12/3/03. On 12/3/03 the vaccinee was administered 2002-2003 Fluvirin. No adverse events were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/4/03 concerning an unknown number of 2 year old vaccinees of unknown sex who inadvertently received Fluvirin on an unspecified date. On an unspecified date, an unknown number 2 year old vaccinees inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.25
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a member of staff for a health care professional on 12/5/03 concerning a 15 month old male vaccinee who inadvertently received 0.25ml Fluvirin vaccine on 12/4/03. On 12/4/03 the vaccinee received Fluvirin. No adverse symptoms occurred. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a member of staff for a health care professional on 12/5/03 concerning a 3 year old male who inadvertently received 0.5ml Fluvirin vaccine on 12/3/03. On 12/3/03 the vaccinee received Fluvirin. No adverse symptoms occurred. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.32
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/4/03 concerning a 16 month old female vaccinee who was administered a single dose of Fluvirin vaccine on 12/2/03. On 12/2/03 the vaccinee received Fluvirin. The vaccinee did not exhibit any adverse symptoms at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 2/4/04: A follow up report was received from a health care professional concerning a one and a half year old vaccinee who received Fluvirin on 12/1/03. No adverse events were reported at the time of reporting. No follow up pending, all information received.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/4/03 concerning an unknown number of children less than 4 years of age and of unknown sex who inadvertently received Fluvirin on an unspecified date. On an unspecified date, an unknown number of children less than 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. No follow up pending, all information received.
Age: 71.0
Sex: M
Vaccine: FLU3
Symptoms: Fatigue, Headache, Medication error
Clinical narrative: A report was received from a health care professional on 12/4/03 concerning a 70 year old male vaccinee who experienced headache and fatigue an unspecified length of time following administration of Fluvirin on 12/4/03. The vaccinee inadvertently received two doses of influenza vaccine, one dose of influenza vaccine was administered on an unspecified date several months earlier and Fluvirin was administered on 12/4/03. On 12/4/03, approximately 8 hours after administration of Fluvirin the vaccinee experienced headache and fatigue. There was insufficient information to determine the reporter's causality assessment. Follow up pending.